Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
BMC Immunology|March 21, 2009
Interferon-gamma coordinates CCL3-mediated neutrophil recruitment in vivoCynthia A Bonville, Caroline M Percopo, Kimberly D Dyer, et al.The Journal of Allergy and Clinical Immunology|January 18, 2016
IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3Avanti Desai, Mi-Yeon Jung, Ana Olivera, et al.Arthritis and Rheumatism|June 28, 2006
Abnormal differentiation of memory T cells in systemic lupus erythematosusRuth D Fritsch, Xinglei Shen, Gabor G Illei, et al.The Journal of Allergy and Clinical Immunology|September 4, 2007
Anti-IgE treatment of eosinophil-associated gastrointestinal disordersShabnam Foroughi, Barbara Foster, Nayoung Kim, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2005
Inflammatory responses to pneumovirus infection in IFN-alpha beta R gene-deleted miceTara L Garvey, Kimberly D Dyer, John A Ellis, et al.Plos One|September 10, 2016
Regulation of Reactive Oxygen Species and the Antioxidant Protein DJ-1 in MastocytosisDo-Kyun Kim, Michael A Beaven, Joseph M Kulinski, et al.The Journal of Allergy and Clinical Immunology|October 4, 2015
Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced functionAlyssa Mitson-Salazar, Yuzhi Yin, Daniel L Wansley, et al.The Laryngoscope|October 5, 2018
Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp sizeTanya M Laidlaw, Calman Prussin, Reynold A Panettieri, et al.The Journal of Allergy and Clinical Immunology|June 5, 2023
Safety and Efficacy of Dexpramipexole in Eosinophilic Asthma (EXHALE): A randomized controlled trialSalman Siddiqui, Sally E Wenzel, Michael E Bozik, et al.Blood|May 10, 2018
Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromesSandhya R Panch, Michael E Bozik, Thomas Brown, et al.Pageof 4